Roche breaking ground on Dx expansion; Tornier CEO steps aside;

 @FierceMedDev: Chinese device maker Dehaier Medical saw Q3 revenue dip. The reason: an expansion strategy has yet to fully take hold. More | Follow @FierceMedDev

 @MarkHFierce: PerkinElmer snatched up an infectious disease Dx company based in China. More | Follow @MarkHFierce

 @DamianFierce: Hologic took a dive in the last quarter but predicts its $3.8B Gen-Probe buy will brighten the future. Story | Follow @DamianFierce

> Response Genetics ($RGDX) narrowed its quarterly losses to $1.4 million in Q3, growing revenue by 6% to $5.4 million. More

> Tornier Medical ($TRNX) CEO Douglas Kohrs is retiring from the company, and COO David Mowry will serve in the interim while Tornier searches for a permanent chief. Report

> In Italy, authorities have arrested 9 cardiologists for participating in illegal and unauthorized clinical trials. The investigation is said to implicate 67 others and 12 medical equipment companies. Story

> Roche Diagnostics ($RHHBY) is set to break ground Wednesday on Phase I of its $300 million expansion in Indianapolis. News

> Stryker ($SYK) has signed on with Wineman Technology, tasking the company with developing 5 life-cycle and durability test systems for its devices. Release

> Is St. Jude Medical ($STJ) on pace to rebound or doomed to tank? Two analysts have widely divergent takes. Item

Biotech News

 @FierceBiotech: Trending on FierceBiotech.com: 10 Top Women in Biotech 2012. Special Report | Follow @FierceBiotech

 @JohnCFierce: Alnylam to pay $75M to settle legal squabble over Tekmira's RNAi delivery tech. Story | Follow @JohnCFierce

 @RyanMFierce: $GILD is looking smart today for buying 7977. Market cap appears to have jumped $6.8B yesterday on news of its 100% SVR with hep C slayer. | Follow @RyanMFierce

> Fast-growing Gilead Sciences blueprints expansion, new R&D hires. News

> Pearl lands $65M round to fuel PhIII COPD showdown with Novartis, GSK. Story

Pharma News

@FiercePharma: Israeli legal scholars move to sue Teva for shrouding details on executive pay. More | Follow @FiercePharma

> GSK ($GSK) rep wears dunce cap for off-label breach in U.K. Article

> Boycott Roche ($RHHBY) to open Tamiflu data, critic says. News

Biotech Research News

> Harvard's microchip, lined with living cells, mimics disease in preclinical drug test. Report

> Stem cells produce the next potential Alzheimer's treatment. Item

> Kancera credits new drug with slowing pancreatic cancer tumor growth. Article

> Anti-inflammatory drugs that minimize infection risk appear possible. News

> Scientists crack genetic code for rare childhood leukemia variation. Story

Pharma Manufacturing News

> Lundbeck manufacturing starts small in China. Report

> Orchid closing up shop in China. More

> EFCG demands EU inspections of foreign API makers. Article

> FDA confirms Novartis plant, renewing CEO's confidence. Story

> Pilot shows national track and trace 'not insurmountable'. Editor's Corner

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,